Agios Pharmaceuticals (AGIO) Competitors $27.82 +0.30 (+1.09%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$27.82 0.00 (-0.02%) As of 04/15/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AGIO vs. TGTX, RVMD, BBIO, LEGN, BPMC, SRPT, TLX, AXSM, KRYS, and NUVLShould you be buying Agios Pharmaceuticals stock or one of its competitors? The main competitors of Agios Pharmaceuticals include TG Therapeutics (TGTX), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Legend Biotech (LEGN), Blueprint Medicines (BPMC), Sarepta Therapeutics (SRPT), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Axsome Therapeutics (AXSM), Krystal Biotech (KRYS), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. Agios Pharmaceuticals vs. TG Therapeutics Revolution Medicines BridgeBio Pharma Legend Biotech Blueprint Medicines Sarepta Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Axsome Therapeutics Krystal Biotech Nuvalent Agios Pharmaceuticals (NASDAQ:AGIO) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends, valuation and community ranking. Does the MarketBeat Community believe in AGIO or TGTX? TG Therapeutics received 168 more outperform votes than Agios Pharmaceuticals when rated by MarketBeat users. Likewise, 76.27% of users gave TG Therapeutics an outperform vote while only 66.98% of users gave Agios Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAgios PharmaceuticalsOutperform Votes49166.98% Underperform Votes24233.02% TG TherapeuticsOutperform Votes65976.27% Underperform Votes20523.73% Which has better earnings and valuation, AGIO or TGTX? Agios Pharmaceuticals has higher earnings, but lower revenue than TG Therapeutics. Agios Pharmaceuticals is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgios Pharmaceuticals$36.50M43.67$673.72M$11.342.45TG Therapeutics$329.00M18.63$12.67M$0.14278.79 Do analysts recommend AGIO or TGTX? Agios Pharmaceuticals presently has a consensus price target of $56.57, indicating a potential upside of 103.35%. TG Therapeutics has a consensus price target of $40.67, indicating a potential upside of 4.19%. Given Agios Pharmaceuticals' higher probable upside, research analysts plainly believe Agios Pharmaceuticals is more favorable than TG Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agios Pharmaceuticals 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Does the media favor AGIO or TGTX? In the previous week, Agios Pharmaceuticals had 3 more articles in the media than TG Therapeutics. MarketBeat recorded 16 mentions for Agios Pharmaceuticals and 13 mentions for TG Therapeutics. TG Therapeutics' average media sentiment score of 1.24 beat Agios Pharmaceuticals' score of 0.86 indicating that TG Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agios Pharmaceuticals 11 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive TG Therapeutics 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in AGIO or TGTX? 58.6% of TG Therapeutics shares are held by institutional investors. 4.9% of Agios Pharmaceuticals shares are held by insiders. Comparatively, 10.5% of TG Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, AGIO or TGTX? Agios Pharmaceuticals has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 2.14, indicating that its stock price is 114% more volatile than the S&P 500. Is AGIO or TGTX more profitable? Agios Pharmaceuticals has a net margin of 1,845.92% compared to TG Therapeutics' net margin of -5.42%. Agios Pharmaceuticals' return on equity of -2.51% beat TG Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Agios Pharmaceuticals1,845.92% -2.51% -2.26% TG Therapeutics -5.42%-8.32%-3.40% SummaryAgios Pharmaceuticals beats TG Therapeutics on 9 of the 17 factors compared between the two stocks. Remove Ads Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGIO vs. The Competition Export to ExcelMetricAgios PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.59B$6.33B$5.33B$7.57BDividend YieldN/A3.24%5.11%4.32%P/E Ratio2.456.7921.7317.81Price / Sales43.67225.96379.2094.61Price / CashN/A65.6738.1534.64Price / Book1.035.866.464.00Net Income$673.72M$141.86M$3.20B$247.23M7 Day Performance5.86%4.50%2.85%1.45%1 Month Performance-10.05%-12.65%-8.55%-6.24%1 Year Performance-3.40%-11.06%10.46%0.60% Agios Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGIOAgios Pharmaceuticals3.772 of 5 stars$27.82+1.1%$56.57+103.3%-4.9%$1.59B$36.50M2.45390Analyst RevisionNews CoverageTGTXTG Therapeutics3.3148 of 5 stars$37.25-0.3%$40.67+9.2%+177.4%$5.85B$329.00M-372.46290Positive NewsRVMDRevolution Medicines3.8147 of 5 stars$31.40+0.3%$65.23+107.7%+2.2%$5.84B$742,000.00-8.75250Positive NewsHigh Trading VolumeBBIOBridgeBio Pharma4.5716 of 5 stars$30.67-2.2%$52.64+71.6%+32.9%$5.83B$221.90M-10.76400Analyst ForecastGap DownLEGNLegend Biotech2.409 of 5 stars$30.25-5.5%$79.00+161.2%-34.8%$5.56B$627.24M-31.841,070Positive NewsGap UpBPMCBlueprint Medicines2.6341 of 5 stars$80.20-1.8%$124.95+55.8%-4.4%$5.13B$508.82M-74.26640Positive NewsHigh Trading VolumeSRPTSarepta Therapeutics4.6725 of 5 stars$52.40-3.7%$163.18+211.4%-54.0%$5.08B$1.90B41.92840Short Interest ↑Gap DownHigh Trading VolumeTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$14.25+4.7%$22.00+54.4%N/A$4.81B$783.21M0.00N/AAXSMAxsome Therapeutics4.5823 of 5 stars$98.50-0.4%$169.80+72.4%+52.2%$4.80B$385.69M-16.44380Analyst RevisionKRYSKrystal Biotech4.6447 of 5 stars$166.01-3.1%$220.00+32.5%-0.4%$4.78B$290.52M55.52210NUVLNuvalent1.9873 of 5 stars$64.68-1.6%$113.44+75.4%+8.4%$4.63BN/A-18.6440Positive News Remove Ads Related Companies and Tools Related Companies TG Therapeutics Alternatives Revolution Medicines Alternatives BridgeBio Pharma Alternatives Legend Biotech Alternatives Blueprint Medicines Alternatives Sarepta Therapeutics Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Axsome Therapeutics Alternatives Krystal Biotech Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AGIO) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AGIO Stock Free AGIO Stock Alerts